INDP
Indaptus Therapeutics Inc
2.40$
+12.3%
vs. previous close
Closing price · As of: Oct 2, 2026
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 15 | Q4 15 | Q1 17 | Q2 17 | Q3 17 | Q4 17 | Q1 18 | Q2 18 | Q3 18 | Q4 18 | Q1 19 | Q2 19 | Q3 19 | Q4 19 | Q1 20 | Q2 20 | Q3 20 | Q4 20 | Q1 21 | Q2 21 | Q3 21 | Q4 21 | Q1 22 | Q2 22 | Q3 22 | Q4 22 | Q1 23 | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -100.0% | – | – | – | -100.0% | – | – | – | – | – | – | |
| – | +105.0% | +20.3% | – | – | +1.4% | -4.6% | +1.9% | +6.2% | -1.3% | -0.9% | -2.3% | -0.5% | -0.5% | – | – | – | – | – | +76.7% | – | – | -0.2% | +0.0% | -26.6% | -18.1% | +0.0% | +0.3% | -0.3% | -0.3% | +129.7% | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -145.7% | – | – | – | – | – | – | – | – | – | – | |
| – | +37.4% | +91.2% | +43.5% | +4.8% | +50.6% | +0.1% | -5.4% | -7.0% | +32.1% | -17.2% | -8.0% | +7.5% | -78.6% | -79.3% | +240.5% | +5.9% | -73.9% | +39.1% | -20.1% | +78.4% | +35.4% | +37.3% | +16.1% | +6.9% | +18.8% | -1.7% | -21.2% | +50.4% | -8.6% | -21.8% | +7.7% | -14.5% | +69.2% | +13.3% | -22.9% | -30.0% | +87.5% | -82.7% | -26.1% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | +781.4% | -87.9% | +111.8% | -70.2% | +10.7% | +1,841.7% | -14.8% | -7.4% | +12.3% | -17.8% | +12.0% | +18.4% | -21.8% | +0.3% | +6.1% | +9.7% | +1.8% | -30.0% | +0.9% | +4.1% | +30.0% | -50.6% | +369.6% | -68.6% | -13.3% | – | |
| – | +22.8% | +75.1% | +47.9% | +6.9% | +43.0% | +3.5% | -1.9% | -10.6% | +31.6% | -14.0% | -6.9% | +6.1% | -67.3% | -83.2% | +410.9% | -46.8% | -50.3% | -20.1% | -13.9% | +537.1% | -4.4% | +5.7% | +13.7% | -8.2% | +15.0% | +9.0% | -21.5% | +21.5% | -1.6% | -5.7% | +4.2% | -23.5% | +32.8% | +9.6% | -2.5% | -40.6% | +207.9% | -73.5% | -16.2% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | +7,400.0% | -76.9% | +339.4% | – | – | – | – | – | – | -8.0% | – | – | – | -97.6% | +4,132.2% | +5.5% | -8.6% | +155.3% | +400.4% | -53.2% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | +117.2% | +133.3% | -211.6% | – | -40.4% | +11.8% | -26.3% | +1,821.4% | – | – | +1,226.9% | – | – | -35.0% | +8,954.9% | -101.1% | – | – | – | – | – | – | – | -10,573.4% | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Showing the most recent 40 periods — older statements are on file for this stock.
Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.